| Product NDC: | 0338-0017 | 
| Proprietary Name: | DEXTROSE | 
| Non Proprietary Name: | DEXTROSE MONOHYDRATE | 
| Active Ingredient(s): | 50 g/1000mL & nbsp; DEXTROSE MONOHYDRATE | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0338-0017 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA016673 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100616 | 
| Package NDC: | 0338-0017-01 | 
| Package Description: | 150 mL in 1 BAG (0338-0017-01) | 
| NDC Code | 0338-0017-01 | 
| Proprietary Name | DEXTROSE | 
| Package Description | 150 mL in 1 BAG (0338-0017-01) | 
| Product NDC | 0338-0017 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | DEXTROSE MONOHYDRATE | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20100616 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | DEXTROSE MONOHYDRATE | 
| Strength Number | 50 | 
| Strength Unit | g/1000mL | 
| Pharmaceutical Classes |